Allergen immunotherapy: a practice parameter third update. - Wikidata - awgldk - TriplyDB

Allergen immunotherapy: a practice parameter third update.

Allergen immunotherapy: a practice parameter third update.

http://www.wikidata.org/entity/Q52712682

about

Sublingual immunotherapy for asthma Allergen-specific immunotherapy in pediatric allergic asthma Management of the polyallergic patient with allergy immunotherapy: a practice-based approach Allergen immunotherapy in pregnancy Stinging insect allergy: current perspectives on venom immunotherapy Difficult-to-control asthma: epidemiology and its link with environmental factors Child with atopic dermatitis Sublingual immunotherapy in allergic rhinitis: efficacy, safety, adherence and guidelines Antigen-specific tolerance in immunotherapy of Th2-associated allergic diseases.Breathing Better Through Bugs: Asthma and the Microbiome Efficacy and safety of ragweed sublingual immunotherapy in Canadian patients with allergic rhinoconjunctivitis Allergen-specific immunotherapy: is it vaccination against toxins after all?Risk and safety requirements for diagnostic and therapeutic procedures in allergology: World Allergy Organization Statement Decision-making analysis for allergen immunotherapy versus nasal steroids in the treatment of nasal steroid-responsive allergic rhinitis.Sublingual immunotherapy: World Allergy Organization position paper 2013 update.Subcutaneous and Sublingual Immunotherapy in Allergic Asthma in Children Patients on subcutaneous allergen immunotherapy are at risk of intramuscular injections.Current status of standardization of inhalant allergen extracts in Korea Changes in skin reactivity and associated factors in patients sensitized to house dust mites after 1 year of allergen-specific immunotherapy.International consensus on (ICON) anaphylaxis Allergen sensitization linked to climate and age, not to intermittent-persistent rhinitis in a cross-sectional cohort study in the (sub)tropics Development of a poly (lactic-co-glycolic acid) particle vaccine to protect against house dust mite induced allergy Clinical practice guideline: Allergic rhinitis.Mapping systematic reviews on atopic eczema--an essential resource for dermatology professionals and researchers.Clinical contraindications to allergen immunotherapy: an EAACI position paper.Safety of accelerated schedules of subcutaneous allergen immunotherapy with house dust mite extract in patients with atopic dermatitis."The value of pre- and co-seasonal sublingual immunotherapy in pollen-induced allergic rhinoconjunctivitis".The effect of a new communication template on anticipated willingness to initiate or resume allergen immunotherapy: an internet-based patient survey The safety of self-administered allergen immunotherapy during the buildup and maintenance phases Prolonged efficacy of the 300IR 5-grass pollen tablet up to 2 years after treatment cessation, as measured by a recommended daily combined score Choosing wisely: practical considerations on treatment efficacy and safety of asthma in the elderly.Fear of repeated injections in children younger than 4 years receiving subcutaneous allergy immunotherapy.Laser-facilitated epicutaneous immunotherapy to IgE-mediated allergy.Severe asthma in children.Consensus Guidelines for the Treatment of Atopic Dermatitis in Korea (Part II): Systemic Treatment.Efficacy of allergen immunotherapy in reducing the likelihood of developing new allergen sensitizations: a systematic review.Allergen immunotherapy for the treatment of allergic rhinitis and/or asthma: an umbrella review Allergen immunotherapy in allergic respiratory diseases: from mechanisms to meta-analyses The Saudi initiative for asthma - 2012 update: Guidelines for the diagnosis and management of asthma in adults and children An accelerated dose escalation with a grass pollen allergoid is safe and well-tolerated: a randomized open label phase II trial.

P2860

Q24187736-F15527B0-6826-43E4-AB30-A4F4B4216E6D Q26739254-F4EFEEBA-CD3A-4E25-8869-B5CBCCC9BEE0 Q26772200-3A23D51E-99F5-4EE5-BA73-02AB3F34A2BC Q26777435-11E8B54C-C0AC-4736-BAC2-EC10C67927C6 Q26801123-2846F260-8C84-412B-84BA-DA80A9D5AB4D Q26801445-426BE0EE-6411-4E5C-BC6B-062C6E502E21 Q26830792-5BE10699-325D-4751-BC2A-1068CBD6087C Q27002341-64F6D7E7-0C3C-4B57-9A69-B65D5C5D7FC9 Q27687250-8E16EF4D-75EF-449F-B635-29C4A51DF3F6 Q28067227-C83057AF-8D04-4517-A88D-A26BC7F7CBF8 Q28390024-AB00ADD1-0B10-477E-87A4-40E0BC7B5CDC Q30248317-EBB5767D-89EB-42D1-9048-A307C9B67BD9 Q30371972-DABC170C-6D2D-4FF7-959A-68580FDB1277 Q30415158-0A05572C-F3EB-4A34-B910-2A48F803E18E Q30440195-B5C37ECD-F984-4497-B6D5-662B7ABAAD67 Q33586188-2C8C39CD-BA64-4F8E-BEE1-EF050835B383 Q33595034-B405B81D-3468-4FE7-98E5-546346EA3FBC Q33612208-B9BFD03E-7ECB-4858-950F-666C0FE8B5DF Q33619064-9F7EE314-2709-43BE-BE1F-C8CB22594671 Q33687257-53B864EA-C2FF-40D0-AC7E-4F46697C642D Q33815162-6FEBA0A5-1FAF-4D3F-924D-0209F1BED9E3 Q34099820-5D5C791E-9D54-4BA6-8F4F-8D3545A4A4B5 Q34460983-6007C476-8541-4D60-BD9B-92B2F6F18A4E Q34625848-FCA936E2-B19A-4584-A478-40D72CF211A4 Q34669524-ED66A1C7-A3F3-4BCE-BA50-1DADE22AE95B Q35211932-84E1EF45-5607-43D0-8C88-9A82A2E15E45 Q35564301-0C28DD40-BC66-4386-8DAA-8C26178D5E48 Q35645654-189AC63A-A788-4255-B0E1-EEF05F53DB48 Q35733569-D5C5DAF9-B65C-4B82-B0A3-F8099392B9AF Q35761230-D2408DC0-F431-44A1-9BCD-20C56F46E098 Q35765263-CE8EDDA4-B0A9-429C-A9D8-35B6960934CD Q35928176-4A9EFC9A-A251-4D3C-AE2F-B6EC16C9CE32 Q36033148-53C833F1-96E3-40A8-9C72-C5954A1C161A Q36108246-A4E9D75B-6896-45EC-AAD8-3ACC250D84D7 Q36214254-DC944D14-7D5A-408E-AA8D-C64CD81F2123 Q36215069-97983F15-49EA-4DDB-8E9C-798C969E0E4B Q36369716-B29AE2B6-7FC4-4873-8B87-57A569A68BF6 Q36411170-3A727FAE-6C34-4E23-BE3F-7BB1D95699B6 Q36422663-F79EA1D5-C084-48BD-9536-F5E1E876D65F Q36529630-6EC02C34-B85D-41F1-BFDA-CDEF68CECAC9

P2860

Allergen immunotherapy: a practice parameter third update.

http://www.wikidata.org/entity/Q52712682

description

2010 nî lūn-bûn

@nan

2010年の論文

@ja

2010年学术文章

@wuu

2010年学术文章

@zh

2010年学术文章

@zh-cn

2010年学术文章

@zh-hans

2010年学术文章

@zh-my

2010年学术文章

@zh-sg

2010年學術文章

@yue

2010年學術文章

@zh-hant

name

Allergen immunotherapy: a practice parameter third update.

@en

Allergen immunotherapy: a practice parameter third update.

@nl

type

label

Allergen immunotherapy: a practice parameter third update.

@en

Allergen immunotherapy: a practice parameter third update.

@nl

prefLabel

Allergen immunotherapy: a practice parameter third update.

@en

Allergen immunotherapy: a practice parameter third update.

@nl

P1433

Q52712682-07944FD6-4D10-4BC6-9475-53CC3D12F128

P1476

Q52712682-B9B533A4-49CF-47D4-8AFF-889DF141F1C2

P2093

Q52712682-0429DC1F-A492-44E7-A4B7-6FDD4834ABCF

Q52712682-0C3CC616-C4CB-4658-B0EB-F1139EF09D9C

Q52712682-11E9FAA8-9DA2-446B-9794-675FF29C6278

Q52712682-1430F915-0539-491F-A1B8-48FB37317C2A

Q52712682-17626E78-69BA-4002-BFE5-D19A232BD1F1

Q52712682-1CF3BB7F-6ED8-4F90-84BF-9A79A80A6305

Q52712682-259131F3-D3D4-4F4D-B957-294F63E52B5F

Q52712682-32CAEF5F-8C8D-4986-BA06-14B634627EEF

Q52712682-4C3CB06A-72D1-4C12-97D8-28B9F1DF1DA7

Q52712682-4C8B112A-C2EA-4F15-A605-F61E33EBD073

P304

Q52712682-3477FC11-8A6C-4C1E-AAFF-F7A675320B12

P31

Q52712682-C93A6AA3-6F44-4BC7-AD73-D67A4D80D6B7

P356

Q52712682-AFEE65A4-F975-49D8-823B-640F7E6ACE8C

P407

Q52712682-7EB6AADA-DBCF-40D6-BDBA-EC353CA2E712

P433

Q52712682-BF35A474-1C56-4425-8C7E-DF494CF23C71

P478

Q52712682-0E20134A-4682-4E77-8F26-A1A87A21DD9D

P577

Q52712682-767FB318-197D-41E0-ACAD-D6A4BBE02111

P5875

Q52712682-4ED7A296-5DA0-4575-B32F-869186DC843F

P698

Q52712682-526FD714-ED1B-432C-B6C7-B5504FA94184

P921

Q52712682-A2327128-AB8F-4B0F-A080-B6B61A178B24

P356

J.JACI.2010.09.034

P1433

The Journal of Allergy and Clinical Immunology

P1476

Allergen immunotherapy: a practice parameter third update.

@en

P2093

Christopher Calabria

http://www.w3.org/2001/XMLSchema#string

Christopher Randolph

http://www.w3.org/2001/XMLSchema#string

Dana Wallace

http://www.w3.org/2001/XMLSchema#string

David A Khan

http://www.w3.org/2001/XMLSchema#string

David I Bernstein

http://www.w3.org/2001/XMLSchema#string

David M Lang

http://www.w3.org/2001/XMLSchema#string

Diane E Schuller

http://www.w3.org/2001/XMLSchema#string

Harold Nelson

http://www.w3.org/2001/XMLSchema#string

Ira Finegold

http://www.w3.org/2001/XMLSchema#string

Jay M Portnoy

http://www.w3.org/2001/XMLSchema#string

P304

S1-55

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.JACI.2010.09.034

http://www.w3.org/2001/XMLSchema#string

P407

P433

1 Suppl

http://www.w3.org/2001/XMLSchema#string

P478

127

http://www.w3.org/2001/XMLSchema#string

P577

2010-12-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

49650140

http://www.w3.org/2001/XMLSchema#string

P698

21122901

http://www.w3.org/2001/XMLSchema#string

P921